Logo image of ALUR

ALLURION TECHNOLOGIES INC (ALUR) Stock Fundamental Analysis

NYSE:ALUR - New York Stock Exchange, Inc. - US02008G2012 - Common Stock - Currency: USD

2.68  -0.08 (-2.9%)

Fundamental Rating

2

Overall ALUR gets a fundamental rating of 2 out of 10. We evaluated ALUR against 72 industry peers in the Diversified Consumer Services industry. ALUR has a bad profitability rating. Also its financial health evaluation is rather negative. ALUR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALUR has reported negative net income.
ALUR had a negative operating cash flow in the past year.
In multiple years ALUR reported negative net income over the last 5 years.
In the past 5 years ALUR always reported negative operating cash flow.
ALUR Yearly Net Income VS EBIT VS OCF VS FCFALUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 20M -20M -40M -60M -80M

1.2 Ratios

Looking at the Return On Assets, with a value of -80.87%, ALUR is doing worse than 87.50% of the companies in the same industry.
Industry RankSector Rank
ROA -80.87%
ROE N/A
ROIC N/A
ROA(3y)-26.72%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALUR Yearly ROA, ROE, ROICALUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -200 -400 -600 -800

1.3 Margins

ALUR has a better Gross Margin (76.20%) than 91.67% of its industry peers.
The Profit Margin and Operating Margin are not available for ALUR so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 76.2%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALUR Yearly Profit, Operating, Gross MarginsALUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 50 -50 -100 -150

More info and screens

2

2. Health

2.1 Basic Checks

ALUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for ALUR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ALUR Yearly Shares OutstandingALUR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 20M 40M 60M 80M
ALUR Yearly Total Debt VS Total AssetsALUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of -9.89, we must say that ALUR is in the distress zone and has some risk of bankruptcy.
ALUR has a worse Altman-Z score (-9.89) than 80.56% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -9.89
ROIC/WACCN/A
WACC21.41%
ALUR Yearly LT Debt VS Equity VS FCFALUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 200M 400M 600M 800M

2.3 Liquidity

ALUR has a Current Ratio of 1.71. This is a normal value and indicates that ALUR is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.71, ALUR is doing good in the industry, outperforming 68.06% of the companies in the same industry.
A Quick Ratio of 1.51 indicates that ALUR should not have too much problems paying its short term obligations.
ALUR has a Quick ratio of 1.51. This is in the better half of the industry: ALUR outperforms 63.89% of its industry peers.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 1.51
ALUR Yearly Current Assets VS Current LiabilitesALUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 20M 40M 60M

More info and screens

3

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-46.91%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-40.55%

3.2 Future

The Earnings Per Share is expected to grow by 15.45% on average over the next years. This is quite good.
The Revenue is expected to grow by 52.33% on average over the next years. This is a very strong growth
EPS Next Y97.32%
EPS Next 2Y32.62%
EPS Next 3Y15.82%
EPS Next 5Y15.45%
Revenue Next Year-10.32%
Revenue Next 2Y15.73%
Revenue Next 3Y16.48%
Revenue Next 5Y52.33%

3.3 Evolution

ALUR Yearly Revenue VS EstimatesALUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M
ALUR Yearly EPS VS EstimatesALUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 0 -2 -4 -6 -8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALUR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALUR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALUR Price Earnings VS Forward Price EarningsALUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALUR Per share dataALUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

ALUR's earnings are expected to grow with 15.82% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.62%
EPS Next 3Y15.82%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALUR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALLURION TECHNOLOGIES INC

NYSE:ALUR (8/8/2025, 8:18:52 PM)

2.68

-0.08 (-2.9%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)05-14 2025-05-14/bmo
Earnings (Next)08-11 2025-08-11
Inst Owners46.34%
Inst Owner Change-25.5%
Ins Owners2.44%
Ins Owner Change0.35%
Market Cap19.99M
Analysts82
Price Target26.14 (875.37%)
Short Float %3.77%
Short Ratio1.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)107.76%
Min EPS beat(2)79.58%
Max EPS beat(2)135.95%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.92%
Min Revenue beat(2)0.02%
Max Revenue beat(2)5.83%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.42
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-9.46
EYN/A
EPS(NY)-1.97
Fwd EYN/A
FCF(TTM)-8.48
FCFYN/A
OCF(TTM)-8.25
OCFYN/A
SpS6.38
BVpS-9.46
TBVpS-9.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -80.87%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 76.2%
FCFM N/A
ROA(3y)-26.72%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 190.66%
Cap/Sales 3.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.71
Quick Ratio 1.51
Altman-Z -9.89
F-Score2
WACC21.41%
ROIC/WACCN/A
Cap/Depr(3y)171.89%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-46.91%
EPS Next Y97.32%
EPS Next 2Y32.62%
EPS Next 3Y15.82%
EPS Next 5Y15.45%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-40.55%
Revenue Next Year-10.32%
Revenue Next 2Y15.73%
Revenue Next 3Y16.48%
Revenue Next 5Y52.33%
EBIT growth 1Y-257.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year48.71%
EBIT Next 3Y22.57%
EBIT Next 5Y16.96%
FCF growth 1Y-6180.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-6007.91%
OCF growth 3YN/A
OCF growth 5YN/A